Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. Has MEDIFAST INC (MED - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.
MEDIFAST INC is one of 177 individual stocks in the Consumer Staples sector. Collectively, these companies sit at #16 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. MED is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for MED's full-year earnings has moved 12.31% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, MED has returned 128.32% so far this year. Meanwhile, the Consumer Staples sector has returned an average of -9.81% on a year-to-date basis. This shows that MEDIFAST INC is outperforming its peers so far this year.
Looking more specifically, MED belongs to the Food - Miscellaneous industry, which includes 42 individual stocks and currently sits at #214 in the Zacks Industry Rank. On average, this group has lost an average of 7.35% so far this year, meaning that MED is performing better in terms of year-to-date returns.
Investors in the Consumer Staples sector will want to keep a close eye on MED as it attempts to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Investors interested in Consumer Staples stocks should always be looking to find the best-performing companies in the group. Has MEDIFAST INC (MED - Free Report) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.
MEDIFAST INC is one of 177 individual stocks in the Consumer Staples sector. Collectively, these companies sit at #16 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. MED is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for MED's full-year earnings has moved 12.31% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, MED has returned 128.32% so far this year. Meanwhile, the Consumer Staples sector has returned an average of -9.81% on a year-to-date basis. This shows that MEDIFAST INC is outperforming its peers so far this year.
Looking more specifically, MED belongs to the Food - Miscellaneous industry, which includes 42 individual stocks and currently sits at #214 in the Zacks Industry Rank. On average, this group has lost an average of 7.35% so far this year, meaning that MED is performing better in terms of year-to-date returns.
Investors in the Consumer Staples sector will want to keep a close eye on MED as it attempts to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MED - FREE